Filter
503
Text search:
drug
approval
Featured
Recommendations
35
New Publications
116
Language
Document type
No document type
294
Studies & Reports
91
Guidelines
67
Manuals
16
Strategic & Response Plan
14
Fact sheets
12
Training Material
6
Resource Platforms
3
Countries / Regions
India
27
South Africa
18
Uganda
16
Global
16
Kenya
15
Western and Central Europe
15
Malawi
12
Ethiopia
11
Nigeria
10
Latin America and the Carribbean
9
Zimbabwe
8
Tanzania
8
Rwanda
8
Bangladesh
8
Ukraine
8
Eastern Europe
8
Ghana
7
Liberia
6
Botswana
6
Myanmar / Burma
6
South–East Asia Region
6
Sierra Leone
5
Nepal
5
Zambia
5
Africa
5
Senegal
4
Philippines
4
Cambodia
4
Namibia
4
Lesotho
4
Asia
4
Tajikistan
4
Russia
4
Thailand
3
Congo, Democratic Republic of
2
Syria
2
Bhutan
2
Venezuela
2
Burkina Faso
1
Cameroon
1
Pakistan
1
South Sudan
1
Afghanistan
1
Germany
1
Lebanon
1
China
1
Sudan
1
Benin
1
Sri Lanka
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Palestine
1
Albania
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
201
Clinical Guidelines
43
Public Health
14
Women & Child Health
14
Key Resources
14
Pharmacy & Technologies
12
Capacity Building
3
Toolboxes
HIV
69
TB
55
AMR
39
Mental Health
31
COVID-19
31
Pharmacy
22
NTDs
13
Rapid Response
10
NCDs
10
Caregiver
8
Global Health Education
5
Planetary Health
5
Ebola & Marburg
4
Refugee
4
Malaria
4
Disability
3
Zika
3
Health Financing Toolbox
3
Polio
2
Conflict
2
Natural Hazards
2
Cholera
1
Specific Hazards
1
Social Ethics
1
2.0 Rapid Response
1
Accessed November 2017
Zhou et al. Int J Ment Health Syst (2019) 13:10 https://doi.org/10.1186/s13033-019-0263-1
In the mid-1980s, recognizing the limitations of traditional training and that the knowledge and skills acquired are not necessarily applied back in the workplace, MSH developed the Monitoring‐Training-Planning (MTP) approach to assist the Ecuadorian Ministry of Health to implement its Child Survi
...
Report of a mission 20–24 April 2015
Introduction
Capter A.1
Ethics and international child and adolescent psychiatry
4–15 February 2013
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to
...
Mpox Molecular Diagnostic Tests(RT-PCR)
recommended
March 2025. Access to appropriate, quality-assured diagnostics remains a challenge. There is limited information on key characteristics of available test kits, including their performance, reliability, and ability to detect relevant Mpox clades. Additionally, the lack of multiplex diagnostic tools c
...
WHO GUIDELINES REVIEW COMMITTEE
Anxiety disorders
Chapter F.5
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the
...
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen
...
Research Article
Hindawi Publishing Corporation
AIDS Research and Treatment
Volume 2011, Article ID 621078, 7 pages doi:10.1155/2011/621078
BMC International Health and Human Rights 2012, 12 :12
http://www.biomedcentral.com/1472-698X/12/12
Externalising disorders
Chapter D.2